These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 24053889
21. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study. Hermans TJ, Fransen van de Putte EE, Horenblas S, Meijer RP, Boormans JL, Aben KK, van der Heijden MS, de Wit R, Beerepoot LV, Verhoeven RH, van Rhijn BW. Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469 [Abstract] [Full Text] [Related]
22. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series. Bruins HM, Arends TJ, Pelkman M, Hulsbergen-van de Kaa CA, van der Heijden AG, Witjes JA. Clin Genitourin Cancer; 2014 Jun; 12(3):190-5. PubMed ID: 24332508 [Abstract] [Full Text] [Related]
23. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M. Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174 [Abstract] [Full Text] [Related]
24. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Simone G, Papalia R, Ferriero M, Guaglianone S, Castelli E, Collura D, Muto G, Gallucci M. Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939 [Abstract] [Full Text] [Related]
25. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K. Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211 [Abstract] [Full Text] [Related]
26. Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report. Rosenblatt R, Johansson M, Alamdari F, Sidiki A, Holmström B, Hansson J, Vasko J, Marits P, Gabrielsson S, Riklund K, Winqvist O, Sherif A. World J Urol; 2017 Jun; 35(6):921-927. PubMed ID: 27738804 [Abstract] [Full Text] [Related]
27. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy. Moschini M, Mattei A, Cornelius J, Shariat SF, Dell'Oglio P, Zaffuto E, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A. World J Urol; 2018 Apr; 36(4):639-644. PubMed ID: 29368231 [Abstract] [Full Text] [Related]
28. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, Thüroff JW. BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265 [Abstract] [Full Text] [Related]
29. Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer. Moschini M, Arbelaez E, Cornelius J, Mattei A, Shariat SF, Dell Oglio P, Zaffuto E, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A. Urol Oncol; 2018 Jun; 36(6):307.e9-307.e14. PubMed ID: 29602638 [Abstract] [Full Text] [Related]
34. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M. Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053 [Abstract] [Full Text] [Related]
35. Occult Nodal Metastases in Patients Down-Staged to Nonmuscle Invasive Disease Following Neoadjuvant Chemotherapy. Nassiri N, Ghodoussipour S, Maas M, Nazemi A, Asanad K, Pearce S, Bhanvadia SS, Djaladat H, Schuckman A, Daneshmand S. Urology; 2020 Aug; 142():155-160. PubMed ID: 32268173 [Abstract] [Full Text] [Related]
36. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer. Kanatani A, Nakagawa T, Kawai T, Naito A, Sato Y, Yoshida K, Nozaki K, Nagata M, Yamada Y, Azuma T, Suzuki M, Fujimura T, Fukuhara H, Nishimatsu H, Kume H, Igawa Y, Homma Y. Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839 [Abstract] [Full Text] [Related]
37. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF. Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854 [Abstract] [Full Text] [Related]
38. Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation. Goldsmith B, Baumann BC, He J, Tucker K, Bekelman J, Deville C, Vapiwala N, Vaughn D, Keefe SM, Guzzo T, Malkowicz SB, Christodouleas JP. Int J Radiat Oncol Biol Phys; 2014 Mar 01; 88(3):603-10. PubMed ID: 24411628 [Abstract] [Full Text] [Related]
39. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. Abdollah F, Sun M, Schmitges J, Djahangirian O, Tian Z, Jeldres C, Perrotte P, Shariat SF, Montorsi F, Karakiewicz PI. BJU Int; 2012 Apr 01; 109(8):1147-54. PubMed ID: 21883849 [Abstract] [Full Text] [Related]
40. The role of 18F-FDG PET/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer. Moussa M, Chakra MA, Saad W, Dellis A, Papatsoris A. Urol Oncol; 2021 Dec 01; 39(12):833.e9-833.e17. PubMed ID: 34059435 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]